Adsilico: Northern Gritstone and Parkwalk Advisors inject 3.5M to advance adsilico's in-silico trials
Virtual human trials or "in-silico trials" are changing the field of clinical research. These computer-simulated trials are used... The post Northern Gritstone and Parkwalk Advisors inject £3.5M to advance adsilico's in-silico trials appeared first on Tech Funding News.
Read full article »
Adsilico is an England-based computational medicine company that develops AI-powered virtual trial models and simulations for the medical device industry.
Read more